Apple Inc. (AAPL) Not a Consumer Favorite Anymore?

Page 1 of 2

Apple Inc. (NASDAQ:AAPL) is setting revenue records and continues to have a very loyal fan base over the last 30 years. But is that loyalty starting to wane? It might be too early to make that call yet, but at least in the categories of technology where Apple has been in the lead in innovation – the smartphone and the tablet – Apple’s loyalty is not as strong as that of Samsung Electronics Co. Ltd. or Inc. (NASDAQ:AMZN), according to the latest data.

However, according to our own data, Insider Monkey’s secret stock-picking strategy resulted in returns that were 18 percentage points higher than that of the S&P 500. You can learn this secret and put it into practice yourself by checking out our newsletter.

Apple Inc.Based on information in a recently released report measuring customer loyalty, Apple Inc. (NASDAQ:AAPL) has fallen behind in a couple of categories and has been caught in another category, where Cupertino had been the top choice. Samsung Electronics Co. Ltd. was rated No. 1 in customer loyalty in the smartphone segment, and tied Apple in the laptop category. And to really kick sand in Cupertino’s face, the Kindle Fire tablet by Inc. (NASDAQ:AMZN) has won over more customers in terms of loyalty than Apple’s iPad. Apple had won every customer loyalty award from this report since the iPhone was introduced in 2007.

What exactly might be the reason for such a turn of events in the two most prized categories for Apple Inc. (NASDAQ:AAPL)? One theory is a relative lack of innovation at Apple nowadays and the conservative approach to innovation. Samsung could be seen as more cutting-edge in its smartphone features, and Apple seems to wait to see if there is customer interest in a feature before introducing it in its devices.

What is an example of these innovative features that Apple seems slow to implement?

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!